Eden Research receives consumer use authority for Mevalone in Italy

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) CEO Sean Smith speaks to Proactive's Thomas Warner about how the business performed during 2022, before going on to provide more detail about the recent authorisation for its fungicide Mevalone to be used by domestic consumers in Italy. Smith describes it as a rare case of a "highly efficacious product being put into the hands of consumers".

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  254.46
+4.44 (1.78%)
AAPL  311.66
+1.40 (0.45%)
AMD  524.92
-17.60 (-3.24%)
BAC  53.92
+1.52 (2.91%)
GOOG  369.35
+13.67 (3.84%)
META  630.13
+7.15 (1.15%)
MSFT  426.98
-0.36 (-0.08%)
NVDA  218.91
+4.16 (1.94%)
ORCL  234.03
+3.70 (1.60%)
TSLA  420.15
-3.55 (-0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.